IN2014DN08398A - - Google Patents

Info

Publication number
IN2014DN08398A
IN2014DN08398A IN8398DEN2014A IN2014DN08398A IN 2014DN08398 A IN2014DN08398 A IN 2014DN08398A IN 8398DEN2014 A IN8398DEN2014 A IN 8398DEN2014A IN 2014DN08398 A IN2014DN08398 A IN 2014DN08398A
Authority
IN
India
Prior art keywords
biomarker
parkinson
disease
drug
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Dario Alessi
Muratul Muqit
Original Assignee
Univ Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dundee filed Critical Univ Dundee
Publication of IN2014DN08398A publication Critical patent/IN2014DN08398A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN8398DEN2014 2012-04-11 2013-04-10 IN2014DN08398A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201206382A GB201206382D0 (en) 2012-04-11 2012-04-11 Parkinson's disease biomarker
PCT/GB2013/050926 WO2013153386A1 (fr) 2012-04-11 2013-04-10 Biomarqueur de la maladie de parkinson

Publications (1)

Publication Number Publication Date
IN2014DN08398A true IN2014DN08398A (fr) 2015-05-08

Family

ID=46177150

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8398DEN2014 IN2014DN08398A (fr) 2012-04-11 2013-04-10

Country Status (5)

Country Link
US (1) US20150104806A1 (fr)
EP (1) EP2836842A1 (fr)
GB (1) GB201206382D0 (fr)
IN (1) IN2014DN08398A (fr)
WO (1) WO2013153386A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015125702A1 (fr) * 2014-02-18 2015-08-27 公益財団法人東京都医学総合研究所 Biomarqueur de la maladie de parkinson et son utilisation
US11214774B2 (en) * 2015-05-01 2022-01-04 Andrew Man Chung Wo PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment
GB201516342D0 (en) * 2015-09-15 2015-10-28 Univ Dundee Downstream targets of PINK1
WO2017053718A2 (fr) * 2015-09-23 2017-03-30 Boston Medical Center Corporation Biomarqueurs pour la détection précoce de la maladie de parkinson
WO2019028106A1 (fr) * 2017-08-01 2019-02-07 Cove Bio Llc Biomarqueurs associés à la maladie de parkinson
US12253490B2 (en) 2018-03-19 2025-03-18 Regeneron Pharmaceuticals, Inc. Microchip capillary electrophoresis assays and reagents
US12259355B2 (en) 2018-03-19 2025-03-25 Regeneron Pharmaceuticals, Inc. Microchip capillary electrophoresis assays and reagents
CN113227788B (zh) * 2019-03-19 2023-11-21 中南大学湘雅医院 一种辅助诊断和治疗帕金森病的方法和试剂
WO2024081653A2 (fr) * 2022-10-12 2024-04-18 Acurex Biosciences Corporation Méthodes d'abaissement de miro2 pour traiter des maladies neurodégénératives

Also Published As

Publication number Publication date
US20150104806A1 (en) 2015-04-16
WO2013153386A1 (fr) 2013-10-17
GB201206382D0 (en) 2012-05-23
EP2836842A1 (fr) 2015-02-18

Similar Documents

Publication Publication Date Title
IN2014DN08398A (fr)
WO2013066764A3 (fr) Marqueurs de signature de la maladie d'alzheimer et procédés d'utilisation
WO2015031808A3 (fr) Procédés de diagnostic et compositions pour le traitement d'un glioblastome
EP4356960A3 (fr) Biomarqueurs et méthodes de traitement d'états associés à pd-1 et pd-l1
MX358517B (es) Métodos para determinar eficacia de fármacos usando proteínas asociadas a cereblon.
EP2539470A4 (fr) Procédés pour le diagnostic, le pronostic et le traitement de maladies auto-immunes
IL246917A0 (en) Biomarker and early diagnosis methods for Alzheimer's disease
WO2015094995A3 (fr) Biomarqueurs de signature génique de réponse tumorale à des antagonistes de pd-1
WO2014140254A9 (fr) Interface utilisateur améliorée pour l'acquisition, l'affichage et l'analyse de données de diagnostic ophtalmologique
WO2013192274A3 (fr) Méthodes de diagnostic et de traitement chez des sujets atteints d'une résistance à une thérapie anticancéreuse ou présentant un risque de développer une telle résistance
WO2015094996A3 (fr) Biomarqueurs de la signature du gène pd-l1 de la réponse tumorale aux antagonistes de pd-1
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
BR112013022493A2 (pt) equipamento e método para examinar, diagnosticar ou auxiliar no diagnóstico e no tratamento de problemas funcionais de visão
WO2012173976A3 (fr) Procédés et appareil pour évaluer l'activité d'un organe et utilisations de ceux-ci
HK1204544A1 (en) Methods and assessment scales for measuring wrinkle severity
SI2900279T1 (sl) GRPR-antagonisti za detekcijo, diagnozo in zdravljenje GRPR-pozitivnega raka
EP2825886A4 (fr) Moyens et procédés pour le diagnostic et la thérapeutique de maladies
BR112014014960A2 (pt) métodos para o diagnóstico da doença de alzheimer
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
WO2015013508A3 (fr) Procédés permettant de diagnostiquer et de traiter une maladie du système immunitaire
WO2014052685A3 (fr) Dispositifs et méthodes d'analyse monocellulaire
HK1232289A1 (zh) 分拣蛋白作为针对情感/心境障碍的生物标记的用途
NZ729773A (en) Biomarkers for disease progression in melanoma
PH12017502099B1 (en) Methods for diagnosing and assessing treatment for cushing's syndrome
EP2983693A4 (fr) Sept4/arts en tant que suppresseur de tumeur dans le diagnostic, le pronostic et le traitement de troubles hépatiques